Generally, GLP-1 agonist medications are FDA approved for adults aged 18 years and older with certain body mass indexes (BMI) (typically a BMI of 30 or above, or a BMI of 27 or above if you have a weight-related health condition such as hypertension, high cholesterol, weight-related anxiety, liver disease, sleep apnea or PCOS)
Retatrutide is an investigational triple agonist peptide (GIP, GLP-1, and glucagon receptor) currently under clinical development for the management of obesity and type 2 diabetes
Having co-founded one of the largest Botox training institution in the USA, I have consulted and trained thousands of medical providers
Light protection is standard practice
Can you buy retatrutide now
What to verify retatrutide, peptide evidence quality, safety and contraindications How to use it Use this information to prepare sharper questions for a licensed provider